Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
Clinical trial NCT07214688 · RECRUITING
Trial details
- NCT number
- NCT07214688
- Sponsor
- Hackensack Meridian Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-06
- Primary completion
- 2032-01-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.